Control Systems Technology Group, Department of Mechanical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
Department of Radiotherapy, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.
Int J Hyperthermia. 2022;39(1):967-976. doi: 10.1080/02656736.2022.2094475.
Hyperthermia treatments are successful adjuvants to conventional cancer therapies in which the tumor is sensitized by heating. To monitor and guide the hyperthermia treatment, measuring the tumor and healthy tissue temperature is important. The typical clinical practice heavily relies on intraluminal probe measurements that are uncomfortable for the patient and only provide spatially sparse temperature information. A solution may be offered through recent advances in magnetic resonance thermometry, which allows for three-dimensional internal temperature measurements. However, these measurements are not widely used in the pelvic region due to a low signal-to-noise ratio and presence of image artifacts.
To advance the clinical integration of magnetic resonance-guided cancer treatments, we consider the problem of removing air-motion-induced image artifacts. Thereto, we propose a new combined thermal and magnetic susceptibility model-based temperature estimation scheme that uses temperature estimates to improve the removal of air-motion-induced image artifacts. The method is experimentally validated using a dedicated phantom that enables the controlled injection of air-motion artifacts and with in vivo thermometry from a clinical hyperthermia treatment.
We showed, using probe measurements in a heated phantom, that our method reduced the mean absolute error (MAE) by 58% compared to the state-of-the-art near a moving air volume. Moreover, with in vivo thermometry our method obtained a MAE reduction between 17% and 95% compared to the state-of-the-art.
We expect that the combined thermal and magnetic susceptibility modeling used in model-based temperature estimation can significantly improve the monitoring in hyperthermia treatments and enable feedback strategies to further improve MR-guided hyperthermia cancer treatments.
在肿瘤通过加热变得敏感的情况下,热疗治疗是常规癌症治疗的成功辅助手段。为了监测和指导热疗,测量肿瘤和健康组织的温度很重要。典型的临床实践严重依赖于腔内探头测量,这会给患者带来不适,并且只能提供空间稀疏的温度信息。通过磁共振测温的最新进展,可以提供三维内部温度测量,这可能是一个解决方案。然而,由于信噪比低和存在图像伪影,这些测量在盆腔区域并未得到广泛应用。
为了推进磁共振引导癌症治疗的临床应用,我们考虑了去除空气运动引起的图像伪影的问题。为此,我们提出了一种新的基于热和磁导率联合模型的温度估计方案,该方案使用温度估计来改善去除空气运动引起的图像伪影。该方法使用专用的体模进行了实验验证,该体模能够控制空气运动伪影的注入,并进行临床热疗的体内测温。
我们使用加热体模中的探头测量结果表明,与最先进的方法相比,我们的方法在移动空气体积附近将平均绝对误差(MAE)降低了 58%。此外,与最先进的方法相比,我们的方法在体内测温时的 MAE 降低了 17%至 95%。
我们预计,基于模型的温度估计中使用的热和磁导率联合建模可以显著改善热疗监测,并能够实现反馈策略以进一步改善磁共振引导的热疗癌症治疗。